H.R. 3635House117th Congress (2021-2023)Passed House

Strengthening America’s Strategic National Stockpile Act of 2021

AI-Generated Summary

Updated February 8, 2026 at 3:51 AM UTC

The Strengthening America’s Strategic National Stockpile Act of 2021 updates the Public Health Service Act to improve the nation’s emergency medical supplies. It lets the HHS secretary transfer near‑expiry drugs, vaccines, and devices to other federal agencies on a reimbursable basis, requires equipment maintenance, launches a pilot to boost domestic production and reserves of critical supplies, funds a GAO study on user fees, creates a grant program for states to build their own stockpiles, adds new reporting and transparency rules, and raises annual funding for the stockpile.

Key Provisions

Allows reimbursable transfers of supplies less than one year from expiry to other federal agencies, with reporting and a sunset date of September 30 2024.
Adds a duty to keep stockpile equipment in good working order and permits contracts for maintenance services.
Creates a supply‑chain elasticity pilot to increase emergency stock, diversify domestic production, and manage domestic reserves; funded $500 million per year for FY 2022‑2024, authority ends September 30 2024.
Requires the GAO to study the feasibility of user fees to offset procurement costs and report findings by February 1 2024.
Establishes a grant program for states to expand or maintain their own strategic stockpiles, with matching‑fund requirements, technical assistance, and $3.5 billion per year for FY 2022‑2024, ending FY 2024.
Mandates regular congressional reports on COVID‑19 stockpile requests and on cooperative agreements under the pilot program.
Requires HHS to develop transparent, largely unclassified processes for requesting and distributing stockpile supplies, with a report due January 1 2022.
Increases authorized appropriations for the stockpile to $705 million per year for FY 2022‑2024.

Legislative Activity

Stay on top of the latest movement without scrolling through every action

11 earlier actions

SenateIntro Referral Latest Action

Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Health, Education, Labor, and Pensions Committee

October 21, 2021

View full timeline

HouseIntro Referral

Introduced in House

May 28, 2021

HouseIntro Referral

Referred to the House Committee on Energy and Commerce.

Energy and Commerce Committee

May 28, 2021

HouseCommittee

Referred to the Subcommittee on Health.

Health Subcommittee

May 31, 2021

HouseFloor

Mr. Pallone moved to suspend the rules and pass the bill.

October 19, 2021 • 4:31 PM

HouseFloor

Considered under suspension of the rules. (consideration: CR H5651-5654)

October 19, 2021 • 4:31 PM

HouseFloor

DEBATE - The House proceeded with forty minutes of debate on H.R. 3635.

October 19, 2021 • 4:31 PM

HouseFloor

At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.

October 19, 2021 • 4:43 PM

HouseFloor

Considered as unfinished business. (consideration: CR H5701)

October 20, 2021 • 2:40 PM

HouseFloor

Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 397 - 22 (Roll no. 322).(text: CR 10/19/2021 H5651-5653)

View vote Passed

October 20, 2021 • 2:56 PM

HouseFloor

On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 397 - 22 (Roll no. 322). (text: CR 10/19/2021 H5651-5653)

View vote Passed

October 20, 2021 • 2:56 PM

HouseFloor

Motion to reconsider laid on the table Agreed to without objection.

October 20, 2021 • 2:56 PM

SenateIntro Referral

Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Health, Education, Labor, and Pensions Committee

October 21, 2021

Voting History

1 vote recorded • Roll call available

HOUSE

Roll Call Available

October 20, 2021 at 2:53 PM

On Motion to Suspend the Rules and Pass

Majority required: 2/3 (66.7%)

Passed

397 - 22

Floor Debate

9 members

What members said about H.R. 3635 on the floor

7 Republicans2 Democrats

Rep. Frank Pallone, Jr.D-NJ-6 · Oct 19, 2021

Madam Speaker, I move to suspend the rules and pass the bill (H.R. 3635) to amend the Public Health Service Act with respect to the Strategic National Stockpile, and for other purposes. Madam…

Madam Speaker, I move to suspend the rules and pass the bill (H.R. 3635) to amend the Public Health Service Act with respect to the Strategic National Stockpile, and for other purposes.

Madam Speaker, I ask unanimous consent that all Members may have 5 legislative days in which to revise and extend their remarks and include extraneous material on H.R. 3635.

Madam Speaker, I yield myself such time as I may consume.

Madam Speaker, I rise today in support of H.R. 3635, the Strengthening America's Strategic National Stockpile Act of 2021.

This bill makes long-overdue improvements to the Strategic National Stockpile to ensure we have access to critical lifesaving medical supplies during public health emergencies. Since the beginning of the COVID-19 pandemic, there has been a lot of attention around the Strategic National Stockpile and our preparedness for this pandemic.

The stockpile was not stocked as it should have been and this bill makes important improvements to correct that for the future. The bill will ensure that the Strategic National Stockpile, also known as SNS, is operating at its highest potential moving forward in order to continue to respond to COVID-19, and also to prepare for the next public health emergency.

This bipartisan bill seeks to reduce America's dependence on foreign sources of critical medical supplies, including personal protective equipment. It does this by boosting domestic manufacturing to make those supplies in the United States and promoting private-public partnerships to ensure a coordinated response. The legislation also makes needed improvements to the Strategic National Stockpile to ensure it is fully equipped with medical supplies that are safe and in working order.

Importantly, the bill also improves transparency around the readiness of the Strategic National Stockpile and how requests from States and Tribes are being managed. It also directs the Department of Health and Human Services to develop and implement improved, transparent processes for these types of requests moving forward. This will be critical for ensuring adequate supplies within the Strategic National Stockpile, as well as informing readiness efforts in the States and also at Tribal levels.

As healthcare systems all across our Nation continue to be stretched to the limit combating the COVID-19 Delta variant, we need to continue to push solutions that support our public health and national security response capability. The improvements to the Strategic National Stockpile put forward in this bill are critical to protecting our frontline workers and patients with the supplies that they need to stay safe.

Madam Speaker, I commend the bipartisan leadership of Representatives Slotkin and Hudson in preparing this bill. This bipartisan bill was passed out of the Committee on Energy and Commerce and by this House unanimously last Congress.

Madam Speaker, I encourage my colleagues to once again join me in strong support of this important bill, and I reserve the balance of my time.

Madam Speaker, I have no additional speakers, and I reserve the balance of my time.

Madam Speaker, I reserve the balance of my time.

Madam Speaker, I agree with my colleague that what this bill does is basically take the lessons that we learned from the pandemic about what can be done to improve the Strategic National Stockpile for the future.

Madam Speaker, I ask everyone to support the bill on a bipartisan basis, and I yield back the balance of my time.

Rep. Jackie WalorskiR-IN-2 · Oct 19, 2021

Madam Speaker, I rise today in support of H.R. 3635, the Strengthening America's Strategic National Stockpile Act. A key lesson from the pandemic has been the absolute need to end our dependence on the Chinese Communist Party for the production of medicines, personal protective equipment, and other critical medical supplies.

Now more than ever, we know that secure and resilient supply chains are vital to the safety and success of the American people. It is so critical to focus on breaking our dependency on China and move domestic manufacturing of PPE products back home to the U.S.

Early on in the pandemic, the Department of Homeland Security concluded that China ``intentionally concealed the severity'' of this virus so they could hoard PPE by blocking exports and buying it up through its state-owned enterprises, a theory that has been confirmed time and time again.

In March of 2020, the New York Times reported that factories in China were not authorized to export masks, and all the while bought up much of the world's supply first. In February of last year, Chinese entrepreneurs and aid groups visited pharmacies in affluent countries and emerging markets, buying masks in bulk to send to China.

Similarly, the Sydney Morning Herald reported that the Greenland Group, a Chinese government-backed property giant, instructed its employees worldwide--even accountants and receptionists and their HR teams--to stop what they were doing and bulk buy as many medical supplies as they could in January and February of 2020.

It is quite simple. We must not trust the Chinese Communist Party. The bipartisan legislation before us today is a strong step in the right direction toward strengthening American manufacturing of PPE in Indiana and across the rest of the country.

Specifically, it includes the Medical Supplies for Pandemics Act I led with Congresswoman Dingell, that would enhance medical supply chain elasticity, improve the domestic production of PPE, and partner with private industry to refresh and replenish existing stocks of medical supplies.

Our legislation takes other important measures, such as supporting State efforts to expand and maintain our own stockpiles, improving maintenance of the national stockpile to ensure it is in good working order and allow the transfer of stockpile items nearing their expiration dates to other federal agencies.

To prepare for the next crisis and better protect frontline healthcare workers, we need to boost U.S. manufacturing of PPE and strengthen the Strategic National Stockpile.

Madam Speaker, I urge support, and I thank my colleagues.

Rep. Brett GuthrieR-KY-2 · Oct 19, 2021

Madam Speaker, I yield myself such time as I may consume. Madam Speaker, I rise in support of H.R. 3635, Strengthening America's Strategic National Stockpile Act, which was spearheaded by…

Madam Speaker, I yield myself such time as I may consume.

Madam Speaker, I rise in support of H.R. 3635, Strengthening America's Strategic National Stockpile Act, which was spearheaded by Representatives Hudson and Slotkin. This legislation includes several critical initiatives that will improve the Strategic National Stockpile, or SNS.

First, the bill allows the SNS to transfer products between federal agencies and to ensure they are used before their expiration.

Second, the bill directs the Secretary of Health and Human Services to examine user fee agreements, ensure the SNS products are in working order, and allows agreements with domestic producers to improve the supply chain to refresh and replenish existing stocks.

Third, the bill directs the Federal Emergency Management Agency and the Centers for Disease Control and Prevention to report on distributions from the SNS, as well as requests for supplies from State, local, Tribal, and territorial agencies.

Finally, the bill authorizes a pilot program to establish State stockpiles. We must ensure our country is prepared to combat the next health crisis, no matter if it is from a disease, disaster, or terrorism.

Madam Speaker, I urge my colleagues to support this bipartisan legislation to improve and sustain the Strategic National Stockpile, and I reserve the balance of my time.

Madam Speaker, I yield 3 minutes to the gentleman from North Carolina (Mr. Hudson), my colleague, and a primary sponsor of this piece of legislation.

Madam Speaker, I yield 3 minutes to the gentlewoman from Indiana (Mrs. Walorski), a member of the Committee on Ways and Means.

Madam Speaker, I am prepared to close, and I yield myself such time as I may consume.

Madam Speaker, I urge support of this piece of legislation.

Fortunately, the last big pandemic that came across the country was in 1918, the flu pandemic, so over 100 years. What we learned, although it was well-planned and all, the Strategic National Stockpile, until you really face a pandemic like we have, you don't truly understand exactly everything you need to do, although the Strategic National Stockpile was there, it was drawn from, it was used. There were a lot of lessons learned.

Madam Speaker, it is important that we apply these lessons. I appreciate my colleagues for doing this, moving forward. Hopefully, it will be another 100 years or more before we have to use the Strategic National Stockpile, but it certainly is prudent that we are ready.

Madam Speaker, I urge the passage of this legislation, and I yield back the balance of my time.

Rep. Richard HudsonR-NC-8 · Oct 19, 2021

Madam Speaker, I rise in support of H.R. 3635, Strengthening America's Strategic National Stockpile Act of 2021, a bill I am proud to have introduced along with Representative Slotkin. The COVID-19…

Rep. Garret GravesR-LA-6 · Oct 20, 2021

Madam Speaker, I was the only member on the climate committee available to preside over a hearing during this vote. Had I been present, I would have voted ``yea'' on rollcall No. 322. Members…

Show 4 more

Rep. Cathy McMorris RodgersR-WA-5 · Oct 20, 2021

Madam Speaker, on October 20, 2021, I was not present for the vote on H.R. 3635, the Strengthening America's Strategic National Stockpile Act of 2021. Had I been present for the vote, I would have…

Rep. Teresa Leger FernandezD-NM-3 · Oct 25, 2021

Madam Speaker, had I been present on October 20, 2021 during Roll Call vote No. 322 for H.R. 3635, the Strengthening America's Strategic National Stockpile Act of 2021, I would have voted

Rep. John JoyceR-PA-13 · Oct 20, 2021

Madam Speaker, had I been present, I would have voted ``yea'' on rollcall No. 322.

Rep. Bob GoodR-VA-5 · Oct 19, 2021

Madam Speaker, on that I demand the yeas and nays.

Bill Text

3 versions available

Reading Mode

Raw Text PDF XML

Referred in SenateIssued October 21, 2021

IIB

117th CONGRESS

1st Session

H. R. 3635

IN THE SENATE OF THE UNITED STATES

October 21, 2021

Received; read twice and referred to the Committee on Health, Education, Labor, and Pensions

AN ACT

To amend the Public Health Service Act with respect to the Strategic National Stockpile, and for other purposes.

Short title; table of contents

(a)

Short title

This Act may be cited as the Strengthening America’s Strategic National Stockpile Act of 2021.

(b)

Table of contents

The table of contents for this Act is as follows:

Sec. 1. Short title; table of contents.

Sec. 2. Reimbursable transfers.

Sec. 3. Equipment maintenance.

Sec. 4. Supply chain flexibility manufacturing pilot.

Sec. 5. GAO study on the feasibility and benefits of a user fee agreement.

Sec. 6. Grants for State strategic stockpiles.

Sec. 7. Action reporting.

Sec. 8. Improved, transparent processes.

Sec. 9. Authorization of appropriations.

Reimbursable transfers

Section 319F–2(a) of the Public Health Service Act (42 U.S.C. 247d–6b(a)) is amended by adding at the end the following:

(6)

Transfers and reimbursements

(A)

In general

Without regard to chapter 5 of title 40, United States Code, the Secretary may transfer to any Federal department or agency, on a reimbursable basis, any drugs, vaccines and other biological products, medical devices, and other supplies in the stockpile if—

(i)

the transferred supplies are less than one year from expiry;

(ii)

the stockpile is able to replenish the supplies, as appropriate; and

(iii)

the Secretary decides the transfer is in the best interest of the United States Government.

(B)

Use of reimbursement

Reimbursement derived from the transfer of supplies pursuant to subparagraph (A) may, to the extent and in the amounts made available in advance in appropriations Acts, be used by the Secretary to carry out this section. Funds made available pursuant to the preceding sentence are in addition to any other funds that may be made available for such purpose.

(C)

Rule of construction

This paragraph shall not be construed to preclude transfers of products in the stockpile under other authorities.

(D)

Report

Not later than September 30, 2023, the Secretary shall submit to the Committee on Energy and Commerce of the House of Representatives and the Committee on Health, Education, Labor, and Pensions of the Senate a report on each transfer made under this paragraph and the amount received by the Secretary in exchange for that transfer.

(E)

Sunset

The authority to make transfers under this paragraph shall cease to be effective on September 30, 2024.

Equipment maintenance

Section 319F–2 of the Public Health Service Act (42 U.S.C. 247d–6b) is amended—

(1)

in subsection (a)(3)—

(A)

in subparagraph (I), by striking ; and and inserting a semicolon;

(B)

in subparagraph (J), by striking the period at the end and inserting a semicolon; and

(C)

by inserting the following new subparagraph at the end:

(K)

ensure contents of the stockpile remain in good working order and, as appropriate, conduct maintenance services on contents of the stockpile; and

; and

(2)

in subsection (c)(7)(B), by adding at the end the following new clause:

(ix)

Equipment maintenance service

In carrying out this section, the Secretary may enter into contracts for the procurement of equipment maintenance services.

Supply chain flexibility manufacturing pilot

(a)

In general

Section 319F–2(a)(3) of the Public Health Service Act (42 U.S.C. 247d–6b(a)(3)), as amended by section 3, is further amended by adding at the end the following new subparagraph:

(L)

enhance medical supply chain elasticity and establish and maintain domestic reserves of critical medical supplies (including personal protective equipment, ancillary medical supplies, and other applicable supplies required for the administration of drugs, vaccines and other biological products, and other medical devices (including diagnostic tests)) by—

(i)

increasing emergency stock of critical medical supplies;

(ii)

geographically diversifying domestic production of such medical supplies, as appropriate;

(iii)

entering into cooperative agreements or partnerships with respect to manufacturing lines, facilities, and equipment for the domestic production of such medical supplies; and

(iv)

managing, either directly or through cooperative agreements with manufacturers and distributors, domestic reserves established under this subparagraph by refreshing and replenishing stock of such medical supplies.

(b)

Reporting; sunset

Section 319F–2(a) of the Public Health Service Act (42 U.S.C. 247d–6b(a)), as amended by section 2, is further amended by adding at the end the following:

(7)

Reporting

Not later than September 30, 2023, the Secretary shall submit to the Committee on Energy and Commerce of the House of Representatives and the Committee on Health, Education, Labor and Pensions of the Senate a report on the details of each cooperative agreement or partnership entered into under paragraph (3)(L), including the amount expended by the Secretary on each such cooperative agreement or partnership.

(8)

Sunset

The authority to enter into cooperative agreements or partnerships pursuant to paragraph (3)(L) shall cease to be effective on September 30, 2024.

(c)

Funding

Section 319F–2(f) of the Public Health Service Act (42 U.S.C. 247d–6b(f)) is amended by adding at the end the following:

(3)

Supply chain elasticity

(A)

In general

For the purpose of carrying out subsection (a)(3)(L), there is authorized to be appropriated $500,000,000 for each of fiscal years 2022 through 2024, to remain available until expended.

(B)

Relation to other amounts

The amount authorized to be appropriated by subparagraph (A) for the purpose of carrying out subsection (a)(3)(L) is in addition to any other amounts available for such purpose.

GAO study on the feasibility and benefits of a user fee agreement

(a)

In general

The Comptroller General of the United States shall conduct a study to investigate the feasibility of establishing user fees to offset certain Federal costs attributable to the procurement of single-source materials for the Strategic National Stockpile under section 319F–2 of the Public Health Service Act (42 U.S.C. 247d–6b) and distributions of such materials from the Stockpile. In conducting this study, the Comptroller General shall consider, to the extent information is available—

(1)

whether entities receiving such distributions generate profits from those distributions;

(2)

any Federal costs attributable to such distributions;

(3)

whether such user fees would provide the Secretary with funding to potentially offset procurement costs of such materials for the Strategic National Stockpile; and

(4)

any other issues the Comptroller General identifies as relevant.

(b)

Report

Not later than February 1, 2024, the Comptroller General of the United States shall submit to the Congress a report on the findings and conclusions of the study under subsection (a).

Grants for State strategic stockpiles

Title III of the Public Health Service Act is amended by inserting after section 319F–4 of such Act (42 U.S.C. 247d–6e) the following new section:

319F–5.

Grants for State strategic stockpiles

(a)

In general

The Secretary may establish a pilot program consisting of awarding grants to States to expand or maintain a strategic stockpile of commercially available drugs, devices, personal protective equipment, and other products deemed by the State to be essential in the event of a public health emergency.

(b)

Allowable use of funds

(1)

Uses

A State receiving a grant under this section may use the grant funds to—

(A)

acquire commercially available products listed pursuant to paragraph (2) for inclusion in the State’s strategic stockpile;

(B)

store, maintain, and distribute products in such stockpile; and

(C)

conduct planning in connection with such activities.

(2)

List

The Secretary shall develop and publish a list of the products that are eligible, as described in subsection (a), for inclusion in a State’s strategic stockpile using funds received under this section.

(3)

Consultation

In developing the list under paragraph (2) and otherwise determining the allowable uses of grant funds under this section, the Secretary shall consult with States and relevant stakeholders, including public health organizations.

(c)

Funding requirement

The Secretary may not obligate or expend any funds to award grants or fund any previously awarded grants under this section for a fiscal year unless the total amount made available to carry out section 319F–2 for such fiscal year is equal to or greater than the total amount of funds made available to carry out section 319F–2 for fiscal year 2022.

(d)

Matching funds

(1)

In general

With respect to the costs of expanding and maintaining a strategic stockpile through a grant under this section, as a condition on receipt of the grant, a State shall make available (directly) non-Federal contributions in cash toward such costs in an amount that is equal to not less than the amount of Federal funds provided through the grant.

(2)

Waiver

The Secretary may waive the requirement of paragraph (1) with respect to a State for the first two years of the State receiving a grant under this section if the Secretary determines that such waiver is needed for the State to establish a strategic stockpile described in subsection (a).

(e)

Technical assistance

The Secretary shall provide technical assistance to States in establishing, expanding, and maintaining a stockpile described in subsection (a).

(f)

Definition

In this section, the term drug has the meaning given to that term in section 201 of the Federal Food, Drug, and Cosmetic Act.

(g)

Authorization of appropriations

To carry out this section, there is authorized to be appropriated $3,500,000,000 for each of fiscal years 2022 through 2024, to remain available until expended.

(h)

Sunset

The authority vested by this section terminates at the end of fiscal year 2024.

Action reporting

(a)

In general

The Secretary of Health and Human Services or the Assistant Secretary for Preparedness and Response, in consultation with the Administrator of the Federal Emergency Management Agency, shall—

(1)

not later than 30 days after the date of enactment of this Act, issue a report to the Committee on Energy and Commerce of the House of Representatives and the Committee on Health, Education, Labor, and Pensions of the Senate regarding all State, local, Tribal, and territorial requests for supplies from the Strategic National Stockpile related to COVID–19; and

(2)

not less than every 30 days thereafter through the end of the emergency period (as such term is defined in section 1135(g)(1)(B) of the Social Security Act (42 U.S.C. 1320b–5(g)(1)(B))), submit to such committees an updated version of such report.

(b)

Reporting period

(1)

Initial report

The initial report under subsection (a) shall address all requests described in such subsection made during the period—

(A)

beginning on January 31, 2022; and

(B)

ending on the date that is 30 days before the date of submission of the report.

(2)

Updates

Each update to the report under subsection (a) shall address all requests described in such subsection made during the period—

(A)

beginning at the end of the previous reporting period under this section; and

(B)

ending on the date that is 30 days before the date of submission of the updated report.

(c)

Contents of report

The report under subsection (a) (and updates thereto) shall include—

(1)

the details of each request described in such subsection, including—

(A)

the specific medical countermeasures, devices, personal protective equipment, and other materials requested; and

(B)

the amount of such materials requested; and

(2)

the outcomes of each request described in subsection (a), including—

(A)

whether the request was wholly fulfilled, partially fulfilled, or denied;

(B)

if the request was wholly or partially fulfilled, the fulfillment amount; and

(C)

if the request was partially fulfilled or denied, a rationale for such outcome.

Improved, transparent processes

(a)

In general

Not later than January 1, 2022, the Secretary of Health and Human Services shall develop and implement improved, transparent processes for the use and distribution of drugs, vaccines and other biological products, medical devices, and other supplies (including personal protective equipment, ancillary medical supplies, and other applicable supplies required for the administration of drugs, vaccines and other biological products, medical devices, and diagnostic tests) in the Strategic National Stockpile under section 319F–2 of the Public Health Service Act (42 U.S.C. 247d–6b) (in this section referred to as the Stockpile).

(b)

Processes

The processes developed under subsection (a) shall include—

(1)

the form and manner in which States, localities, Tribes, and territories are required to submit requests for supplies from the Stockpile;

(2)

the criteria used by the Secretary of Health and Human Services in responding to such requests, including the reasons for fulfilling or denying such requests;

(3)

what circumstances result in prioritization of distribution of supplies from the Stockpile to States, localities, Tribes, or territories;

(4)

clear plans for future, urgent communication between the Secretary and States, localities, Tribes, and territories regarding the outcome of such requests; and

(5)

any differences in the processes developed under subsection (a) for geographically related emergencies, such as weather events, and national emergencies, such as pandemics.

(c)

Classification

The processes developed under subsection (a) shall be unclassified to the greatest extent possible consistent with national security. The Secretary of Health and Human Services may classify portions of such processes as necessary to protect national security.

(d)

Report to Congress

Not later than January 1, 2022, the Secretary of Health and Human Services shall—

(1)

submit a report to the Committee on Energy and Commerce of the House of Representatives and the Committee on Health, Education, Labor, and Pensions of the Senate regarding the improved, transparent processes developed under this section;

(2)

include in such report recommendations for opportunities for communication (by telebriefing, phone calls, or in-person meetings) between the Secretary and States, localities, Tribes, and territories regarding such improved, transparent processes; and

(3)

submit such report in unclassified form to the greatest extent possible, except that the Secretary may include a classified appendix if necessary to protect national security.

Authorization of appropriations

Section 319F–2(f)(1) of the Public Health Service Act (42 U.S.C. 247d–6b(f)(1)) is amended by striking $610,000,000 for each of fiscal years 2019 through 2023 and inserting $705,000,000 for each of fiscal years 2022 through 2024.

Passed the House of Representatives October 20, 2021.

Cheryl L. Johnson,

Clerk